-
2
-
-
84886944380
-
Trial watch: adoptive cell transfer immunotherapy
-
PID: 22737606
-
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautes-Fridman C, et al. Trial watch: adoptive cell transfer immunotherapy. Oncoimmunology. 2012;1(3):306–15.
-
(2012)
Oncoimmunology
, vol.1
, Issue.3
, pp. 306-315
-
-
Galluzzi, L.1
Vacchelli, E.2
Eggermont, A.3
Fridman, W.H.4
Galon, J.5
Sautes-Fridman, C.6
-
3
-
-
84255197842
-
Cancer immunotherapy comes of age
-
COI: 1:CAS:528:DC%2BC3MXhs1GksLjO, PID: 22193102
-
Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480(7378):480–9.
-
(2011)
Nature
, vol.480
, Issue.7378
, pp. 480-489
-
-
Mellman, I.1
Coukos, G.2
Dranoff, G.3
-
4
-
-
84877940678
-
Trial watch: peptide vaccines in cancer therapy
-
PID: 23264902
-
Vacchelli E, Martins I, Eggermont A, Fridman WH, Galon J, Sautes-Fridman C, et al. Trial watch: peptide vaccines in cancer therapy. Oncoimmunology. 2012;1(9):1557–76.
-
(2012)
Oncoimmunology
, vol.1
, Issue.9
, pp. 1557-1576
-
-
Vacchelli, E.1
Martins, I.2
Eggermont, A.3
Fridman, W.H.4
Galon, J.5
Sautes-Fridman, C.6
-
5
-
-
84878002092
-
Trial watch: dendritic cell-based interventions for cancer therapy
-
PID: 23170259
-
Galluzzi L, Senovilla L, Vacchelli E, Eggermont A, Fridman WH, Galon J, et al. Trial watch: dendritic cell-based interventions for cancer therapy. Oncoimmunology. 2012;1(7):1111–34.
-
(2012)
Oncoimmunology
, vol.1
, Issue.7
, pp. 1111-1134
-
-
Galluzzi, L.1
Senovilla, L.2
Vacchelli, E.3
Eggermont, A.4
Fridman, W.H.5
Galon, J.6
-
6
-
-
0030713362
-
Anthracyclines in the treatment of cancer. An overview
-
COI: 1:CAS:528:DyaK2sXntlygu7w%3D, PID: 9361955
-
Hortobagyi GN. Anthracyclines in the treatment of cancer. An overview. Drugs. 1997;54 Suppl 4:1–7.
-
(1997)
Drugs
, vol.54
, pp. 1-7
-
-
Hortobagyi, G.N.1
-
7
-
-
84878019374
-
Trial watch: chemotherapy with immunogenic cell death inducers
-
PID: 22720239
-
Vacchelli E, Galluzzi L, Fridman WH, Galon J, Sautes-Fridman C, Tartour E, et al. Trial watch: chemotherapy with immunogenic cell death inducers. Oncoimmunology. 2012;1(2):179–88.
-
(2012)
Oncoimmunology
, vol.1
, Issue.2
, pp. 179-188
-
-
Vacchelli, E.1
Galluzzi, L.2
Fridman, W.H.3
Galon, J.4
Sautes-Fridman, C.5
Tartour, E.6
-
8
-
-
0036476320
-
From A to Z on CpG
-
COI: 1:CAS:528:DC%2BD38XivVSmu7s%3D, PID: 11929127
-
Krieg AM. From A to Z on CpG. Trends Immunol. 2002;23(2):64–5.
-
(2002)
Trends Immunol
, vol.23
, Issue.2
, pp. 64-65
-
-
Krieg, A.M.1
-
9
-
-
84872801225
-
Trial watch: experimental toll-like receptor agonists for cancer therapy
-
PID: 22934262
-
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautes-Fridman C, et al. Trial watch: experimental toll-like receptor agonists for cancer therapy. Oncoimmunology. 2012;1(5):699–716.
-
(2012)
Oncoimmunology
, vol.1
, Issue.5
, pp. 699-716
-
-
Galluzzi, L.1
Vacchelli, E.2
Eggermont, A.3
Fridman, W.H.4
Galon, J.5
Sautes-Fridman, C.6
-
10
-
-
84861630513
-
An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy
-
COI: 1:CAS:528:DC%2BC38Xot12qsb4%3D, PID: 22666458
-
Zhang H, Liu L, Yu D, Kandimalla ER, Sun HB, Agrawal S, et al. An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy. PLoS One. 2012;7(5):e38111.
-
(2012)
PLoS One
, vol.7
, Issue.5
, pp. e38111
-
-
Zhang, H.1
Liu, L.2
Yu, D.3
Kandimalla, E.R.4
Sun, H.B.5
Agrawal, S.6
-
12
-
-
72149113039
-
Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice
-
COI: 1:CAS:528:DC%2BD1MXhs1Slu7jL
-
Mizuno Y, Naoi T, Nishikawa M, Rattanakiat S, Hamaguchi N, Hashida M, et al. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice. J Control Release Off J Control Release Soc. 2010;141(2):252–9.
-
(2010)
J Control Release Off J Control Release Soc
, vol.141
, Issue.2
, pp. 252-259
-
-
Mizuno, Y.1
Naoi, T.2
Nishikawa, M.3
Rattanakiat, S.4
Hamaguchi, N.5
Hashida, M.6
-
14
-
-
84862673737
-
PLGA-based nanoparticles: an overview of biomedical applications
-
COI: 1:CAS:528:DC%2BC38Xjs1Squr4%3D
-
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release Off J Control Release Soc. 2012;161(2):505–22.
-
(2012)
J Control Release Off J Control Release Soc
, vol.161
, Issue.2
, pp. 505-522
-
-
Danhier, F.1
Ansorena, E.2
Silva, J.M.3
Coco, R.4
Le Breton, A.5
Preat, V.6
-
15
-
-
4544387614
-
Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells
-
PID: 15368253
-
Yoshida M, Babensee JE. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A. 2004;71(1):45–54.
-
(2004)
J Biomed Mater Res A
, vol.71
, Issue.1
, pp. 45-54
-
-
Yoshida, M.1
Babensee, J.E.2
-
16
-
-
58849160540
-
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
-
COI: 1:CAS:528:DC%2BD1MXht12itr4%3D, PID: 19139407
-
Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A. 2009;106(3):870–5.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.3
, pp. 870-875
-
-
Sharp, F.A.1
Ruane, D.2
Claass, B.3
Creagh, E.4
Harris, J.5
Malyala, P.6
-
17
-
-
65349153756
-
T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
-
COI: 1:CAS:528:DC%2BD1MXkslCku7c%3D, PID: 18941113
-
Houot R, Levy R. T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy. Blood. 2009;113(15):3546–52.
-
(2009)
Blood
, vol.113
, Issue.15
, pp. 3546-3552
-
-
Houot, R.1
Levy, R.2
-
18
-
-
22144462478
-
Bioluminescent imaging of melanoma in live mice
-
COI: 1:CAS:528:DC%2BD2MXmvVyrs78%3D, PID: 15982316
-
Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA, et al. Bioluminescent imaging of melanoma in live mice. J Investig Dermatol. 2005;125(1):159–65.
-
(2005)
J Investig Dermatol
, vol.125
, Issue.1
, pp. 159-165
-
-
Craft, N.1
Bruhn, K.W.2
Nguyen, B.D.3
Prins, R.4
Liau, L.M.5
Collisson, E.A.6
-
19
-
-
77958018335
-
Immune regulatory antibodies: are they the next advance?
-
COI: 1:CAS:528:DC%2BC3cXhtFGnurvJ, PID: 20693841
-
Wolchok JD, Yang AS, Weber JS. Immune regulatory antibodies: are they the next advance? Cancer J. 2010;16(4):311–7.
-
(2010)
Cancer J
, vol.16
, Issue.4
, pp. 311-317
-
-
Wolchok, J.D.1
Yang, A.S.2
Weber, J.S.3
-
20
-
-
11144310004
-
Intratumoral immunotherapy: using the tumour against itself
-
COI: 1:CAS:528:DC%2BD2MXlt1KrsA%3D%3D, PID: 15606790
-
Crittenden MR, Thanarajasingam U, Vile RG, Gough MJ. Intratumoral immunotherapy: using the tumour against itself. Immunology. 2005;114(1):11–22.
-
(2005)
Immunology
, vol.114
, Issue.1
, pp. 11-22
-
-
Crittenden, M.R.1
Thanarajasingam, U.2
Vile, R.G.3
Gough, M.J.4
|